Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial

IMPORTANCE: Intravenous eptinezumab, an anti–calcitonin gene-related peptide antibody, is approved for migraine prevention in adults. It has established onset of preventive efficacy on day 1 after infusion. OBJECTIVE: To evaluate the efficacy of and adverse events related to eptinezumab when initiat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA
Main Authors: Winner, Paul K., McAllister, Peter, Chakhava, George, Ailani, Jessica, Ettrup, Anders, Krog Josiassen, Mette, Lindsten, Annika, Mehta, Lahar, Cady, Roger
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2021
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8207242/
https://ncbi.nlm.nih.gov/pubmed/34128999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2021.7665
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados